Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Vortioxetine in Schizophrenia
NCT02357797Phase 4Active, not recruiting
- Sponsor
- Northwell Health
- Start
- Feb 2016
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vortioxetine in schizophrenia, sponsored by Northwell Health. Started Feb 2016; status: active, not recruiting.
02
Drugs
vortioxetine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02357797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357797.